Wim Janssens

机构：Universitair Ziekenhuis Leuven, Ghent University Hospital, KU Leuven · ORCID：0000-0003-1830-2982

发表论文 706 篇 · 总被引 20386 次 · h-index 68

代表论文

• Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials (2026 · The Lancet · 被引 18)
• Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) model (2025 · The Lancet Respiratory Medicine · 被引 9)
• Low mortality and favourable outcome in lung volume reduction surgery for different emphysema morphologies (2025 · European Respiratory Journal · 被引 5)
• Diagnostic criteria for invasive pulmonary aspergillosis in chronic obstructive pulmonary disease patients (2026 · American Journal of Respiratory and Critical Care Medicine · 被引 3)
• Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria (2025 · Interdisciplinary CardioVascular and Thoracic Surgery · 被引 3)
• Clinical Burden of People with Symptomatic and Exacerbating COPD While on Triple Inhaled Therapy (2025 · Journal of Clinical Medicine · 被引 3)